Contrasting XpresSpa Group (XSPA) & Dolby Laboratories (NYSE:DLB)

XpresSpa Group (NASDAQ:XSPA) and Dolby Laboratories (NYSE:DLB) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, dividends, analyst recommendations, earnings and profitability.

Analyst Recommendations

This is a breakdown of current ratings and price targets for XpresSpa Group and Dolby Laboratories, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
XpresSpa Group 0 0 0 0 N/A
Dolby Laboratories 0 2 3 0 2.60

Dolby Laboratories has a consensus price target of $72.75, suggesting a potential upside of 5.56%. Given Dolby Laboratories’ higher possible upside, analysts plainly believe Dolby Laboratories is more favorable than XpresSpa Group.

Volatility and Risk

XpresSpa Group has a beta of -0.99, suggesting that its stock price is 199% less volatile than the S&P 500. Comparatively, Dolby Laboratories has a beta of 0.73, suggesting that its stock price is 27% less volatile than the S&P 500.

Valuation and Earnings

This table compares XpresSpa Group and Dolby Laboratories’ revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
XpresSpa Group $48.82 million 0.09 -$28.84 million ($0.74) -0.22
Dolby Laboratories $1.17 billion 6.10 $122.25 million $2.40 28.72

Dolby Laboratories has higher revenue and earnings than XpresSpa Group. XpresSpa Group is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

12.2% of XpresSpa Group shares are owned by institutional investors. Comparatively, 56.3% of Dolby Laboratories shares are owned by institutional investors. 26.9% of XpresSpa Group shares are owned by insiders. Comparatively, 43.8% of Dolby Laboratories shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Dividends

Dolby Laboratories pays an annual dividend of $0.76 per share and has a dividend yield of 1.1%. XpresSpa Group does not pay a dividend. Dolby Laboratories pays out 31.7% of its earnings in the form of a dividend. Dolby Laboratories has increased its dividend for 3 consecutive years.

Profitability

This table compares XpresSpa Group and Dolby Laboratories’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
XpresSpa Group -84.97% -38.12% -25.36%
Dolby Laboratories 10.43% 12.81% 10.52%

Summary

Dolby Laboratories beats XpresSpa Group on 15 of the 16 factors compared between the two stocks.

XpresSpa Group Company Profile

XpresSpa Group, Inc. operates as a health and wellness services company in the United States and internationally. It operates through two segments, Wellness and Intellectual Property. The Wellness segment offers airport retailer spa services; massage services for the neck, back, feet, and whole body; nail care, such as pedicures, manicures, and polish changes; travel products, including neck pillows, blankets, and massage tools; and cryotherapy, compression, and personal care services, as well as retail products. This segment offers its wellness and travel products through its Website, xpresspa.com. The Intellectual Property segment engages in the monetization of patents related to content and ad delivery, remote monitoring, and computing technologies. As of March 29, 2018, it operated 57 stores in 23 airports. The company was formerly known as FORM Holdings Corp. and changed its name to XpresSpa Group, Inc. in January 2018. XpresSpa Group, Inc. is headquartered in New York, New York.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, including Dolby Digital Plus for digital television, mobile, and Internet-based services; Dolby Digital, a digital audio coding technology that provides multichannel sound in the home; and AAC & HE-AAC, an audio coding technologies used to broadcast, download, and streaming content. Its audio technologies also comprise Dolby TrueHD, an audio coding technology for content providers; Dolby Atmos, an object-oriented audio technology for home theaters, device speakers, and headphones; Dolby AC-4, a digital audio coding system that addresses the current and future needs of broadcast and streaming entertainment services; Dolby Voice, an audio conferencing technology; and Dolby Vision, an imaging technology for cinema, digital television, and other consumer devices, as well as HEVC, a digital video codec with higher bandwidth efficiency used in a range of media devices. In addition, the company designs and manufactures audio and imaging products, such as digital cinema servers, Dolby Cinema audio products, and other products for the film production, cinema, television, broadcast, and entertainment industries. Further, it offers an array of services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. The company serves film studios, content creators, post-production facilities, cinema operators, broadcasters, and video game designers. It sells its products directly to the end users, as well as through dealers and distributors worldwide. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.

Receive News & Ratings for XpresSpa Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XpresSpa Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply